CPRX FY 2019 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$102M+20361.2% YoY

Gross Profit

$88M85.6% margin

Operating Income

$32M31.1% margin

Net Income

$32M31.2% margin

EPS (Diluted)

$0.30

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$35M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$112M

Total Liabilities

$25M

Stockholders' Equity

$88M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$500,000	+20361.2%
Gross Profit	$88M	-$19M	+550.8%
Operating Income	$32M	-$35M	+190.2%
Net Income	$32M	-$34M	+193.7%